Search

In order to carry out mathematical modeling of the drug particles or drop movement in the human respiratory system, an approach to reverse prototyping of the studied areas based on the medical data (computed tomography) results is presented. To adapt the computational grid, a mathematical model of airflow in channels of complex geometry (respiratory system) has been developed. Based on the data obtained, the results of computational experiments for a single-phase system are presented. [ABSTRACT FROM AUTHOR]

In order to carry out mathematical modeling of the drug particles or drop movement in the human respiratory system, an approach to reverse prototyping of the studied areas based on the medical data (computed tomography) results is presented. To adapt the computational grid, a mathematical model of airflow in channels of complex geometry (respiratory system) has been developed. Based on the data obtained, the results of computational experiments for a single-phase system are presented.

This publication discusses polypragmasia and drug interactions in the treatment of uncomplicated acute rhinosinusitis in children and adults. Treatment of rhinosinusitis on an outpatient basis in multimorbid patients may be accompanied by multiple prescriptions, which increases the risk of drug interactions. The article reflects the most significant inappropriate combinations of both medicines and biologically active additives, herbal preparations. The advantages of using drugs with proven effectiveness, in particular intranasal glucocorticosteroids, are considered.

Se mencionan los pilares fundamentales que sustentan a la medicina regenerativa y se señala que de ellos, sin lugar a dudas, el que más ha avanzado es el representado por las células madre, en particular las adultas, que de manera progresiva se han ido extendiendo en la práctica clínica. Se destaca que recién se ha explorado la mucosa nasal como una vía útil y sencilla para el acceso al organismo de elementos potencialmente útiles en la medicina regenerativa, y también como fuente de células madre con posibilidades de introducción en el área clínica. Se comentan las características fundamentales de la mucosa nasal, se mencionan algunos medicamentos que se han usado a través de la ruta intranasal y se refiere la posibilidad de usar esta vía para la administración de células madre que puedan ejercer sus acciones sobre el sistema nervioso central. Estos datos se complementan con los promisorios resultados que se han obtenido con el trasplante de células procedentes de la mucosa nasal.The fundamental pillars of the regenerative medicine were set forth in this paper. One of the most advanced is undoubtedly the field of stem cells, particularly adult stem cells, which has progressively spread into the clinical practice. It was underlined that the nasal mucosa has been recently explored as a useful simple pathway through which the potentially useful elements of regenerative medicine may have access to the body; and also as a source of stem cells with possibilities of being introduced in the clinical area. Comments were made on the fundamental characteristics of the nasal mucosa; some drugs that have been administered through intranasal route were mentioned together with the possibility of using this pathway for stem cells that might have their impact on the central nervous system. All these data were completed with the promising results of transplantation of stem cells from the nasal mucosa.

Intranasal medication for eustachian tube dysfunction (ETD) is an established practice in otolaryngology through the effects of steroids, decongestants, antihistamines or a combination of the above in reducing tubal oedema. The author has previously argued that a double-blind, randomised control trial would be helpful in determining effectiveness of treatment, if a standardised head position, chiefly Mygind or Ragan, was adopted to maximise intranasal drop delivery into the eustachian tube orifice. One recent paper suggests that intranasal treatment is not very effective, but ultimately does not state whether a standardised head position was adopted. Although a large body of evidence supports the hypothesis that the nasal passages are the route to middle ear disease, there is as yet no paper that has been published that has specifically addressed this issue, therefore the author must conclude that evidence to support intranasal treatment for ETD is still lacking and further research is desirable. [ABSTRACT FROM AUTHOR]

Predicting the fate of nasally administered drugs is important for the understanding and possible improvement of in vivo performance. When computational fluid-particle dynamics (CFPD) results are coupled with a physiologically based pharmacokinetic (PBPK) model, drug concentrations in the blood stream can be obtained. Specifically, hybrid CFPD-PBPK simulations can predict inhaled particle transport, deposition, and uptake in the nasal mucus layers and subsequently absorbed drug migration from the nasal cavity to the blood stream.The computer simulation results of Chari et al. (2021) were used as input to a basic PBPK model to track the deposited and dissolved drugs from the nasal cavities to the blood stream. Employing the open-source toolbox OpenFOAM, our PBPK model predictions were compared with experimental in vivo data sets for different corticosteroids. The relative differences between experimental and simulated values of PK metrics, following administration of mometasone furoate nasal spray, were all 7% or less. Drug plasma concentrations based on different drug parameters, such as solubility and partition coefficient, were studied as well. The drug concentration in the plasma was found to increase with an increase in drug solubility (Cs = 0.02 mg/ml, 0.1 mg/ml, 0.2 mg/ml). The same trend was observed for different partition coefficients (K ow = 5e-3, 2, 5000), where the plasma concentration curve peaked for a partition coefficient of 5000. It was also observed that drug dosage controls the amount of residual drug concentrations in the plasma with the passage of time. Two different drug dosages were studied, ie, 50 μg and 800 μg, with the former being completely absorbed in the plasma after 8 h; however, in the latter case the drug was not completely absorbed after that time interval. These modeling and simulation results are useful for planning aspects in drug development, as the predictions provide physical insight to differences in device, formulation, and dosage selection. • PBPK model developed for easy coupling with OpenFOAM CFD solvers. • Nasal uptake simulation results used to predict plasma concentration profiles. • Plasma concentration profiles for different solubility and k o/w values analyzed. [ABSTRACT FROM AUTHOR]